Last reviewed · How we verify
Subunit influenza vaccine
Subunit influenza vaccine is a Biologic drug developed by Insel Gruppe AG, University Hospital Bern. It is currently FDA-approved.
At a glance
| Generic name | Subunit influenza vaccine |
|---|---|
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older (PHASE1)
- Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older (PHASE1)
- Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older
- Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (PHASE2)
- A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months (PHASE3)
- Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals (PHASE1)
- Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older (PHASE1, PHASE2)
- The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Subunit influenza vaccine CI brief — competitive landscape report
- Subunit influenza vaccine updates RSS · CI watch RSS
- Insel Gruppe AG, University Hospital Bern portfolio CI
Frequently asked questions about Subunit influenza vaccine
What is Subunit influenza vaccine?
Subunit influenza vaccine is a Biologic drug developed by Insel Gruppe AG, University Hospital Bern.
Who makes Subunit influenza vaccine?
Subunit influenza vaccine is developed and marketed by Insel Gruppe AG, University Hospital Bern (see full Insel Gruppe AG, University Hospital Bern pipeline at /company/insel-gruppe-ag-university-hospital-bern).
What development phase is Subunit influenza vaccine in?
Subunit influenza vaccine is FDA-approved (marketed).